Search research articles
Contact Us
Filters
Showing results (261-270 of 278) with videos related to
Page
of 28
Sort By:
Biorxiv : the Preprint Server for Biology
|
May 20, 2024
Functional dissection of complex and molecular trait variants at single nucleotide resolution
Layla Siraj, Rodrigo I Castro, Hannah Dewey, et al.
Journal of Medicinal Chemistry
|
July 14, 2026
Discovery of Tivumecirnon (FLX475), a Potent and Selective CCR4 Antagonist That Inhibits the Migration of Immunosuppressive Regulatory T Cells into the Tumor Microenvironment to Restore Antitumor Immunity
Omar Robles, Dirk G Brockstedt, Joel Aponte-Guzman, et al.
ACS Nano
|
August 15, 2023
Nonviral <i>In Vivo</i> Delivery of CRISPR-Cas9 Using Protein-Agnostic, High-Loading Porous Silicon and Polymer Nanoparticles
R Brock Fletcher, Larry D Stokes, Isom B Kelly, et al.
Nature Microbiology
|
December 15, 2021
Synthetic DNA spike-ins (SDSIs) enable sample tracking and detection of inter-sample contamination in SARS-CoV-2 sequencing workflows
Kim A Lagerborg, Erica Normandin, Matthew R Bauer, et al.
Journal of Medicinal Chemistry
|
July 2, 2019
Discovery of a Potent and Selective CCR4 Antagonist That Inhibits T<sub>reg</sub> Trafficking into the Tumor Microenvironment
Jeffrey J Jackson, John M Ketcham, Ashkaan Younai, et al.
Nature
|
February 25, 2026
Functional dissection of complex trait variants at single-nucleotide resolution
Layla Siraj, Rodrigo I Castro, Hannah B Dewey, et al.
Cell
|
November 26, 2013
Coexpression networks implicate human midfetal deep cortical projection neurons in the pathogenesis of autism
A Jeremy Willsey, Stephan J Sanders, Mingfeng Li, et al.
Nature Methods
|
March 20, 2024
Multicenter integrated analysis of noncoding CRISPRi screens
David Yao, Josh Tycko, Jin Woo Oh, et al.
Journal of Medicinal Chemistry
|
September 20, 2022
Potent GCN2 Inhibitor Capable of Reversing MDSC-Driven T Cell Suppression Demonstrates In Vivo Efficacy as a Single Agent and in Combination with Anti-Angiogenesis Therapy
Jeffrey J Jackson, Grant M Shibuya, Buvana Ravishankar, et al.
Science (New York, N.Y.)
|
April 27, 2023
Leveraging base-pair mammalian constraint to understand genetic variation and human disease
Patrick F Sullivan, Jennifer R S Meadows, Steven Gazal, et al.
Page
of 28
Search research articles
Search
Showing results (261-270 of 278) with videos related to
Sort By:
Page
of 28
Biorxiv : the Preprint Server for Biology
|
May 20, 2024
Functional dissection of complex and molecular trait variants at single nucleotide resolution
Layla Siraj, Rodrigo I Castro, Hannah Dewey, et al.
Journal of Medicinal Chemistry
|
July 14, 2026
Discovery of Tivumecirnon (FLX475), a Potent and Selective CCR4 Antagonist That Inhibits the Migration of Immunosuppressive Regulatory T Cells into the Tumor Microenvironment to Restore Antitumor Immunity
Omar Robles, Dirk G Brockstedt, Joel Aponte-Guzman, et al.
ACS Nano
|
August 15, 2023
Nonviral <i>In Vivo</i> Delivery of CRISPR-Cas9 Using Protein-Agnostic, High-Loading Porous Silicon and Polymer Nanoparticles
R Brock Fletcher, Larry D Stokes, Isom B Kelly, et al.
Nature Microbiology
|
December 15, 2021
Synthetic DNA spike-ins (SDSIs) enable sample tracking and detection of inter-sample contamination in SARS-CoV-2 sequencing workflows
Kim A Lagerborg, Erica Normandin, Matthew R Bauer, et al.
Journal of Medicinal Chemistry
|
July 2, 2019
Discovery of a Potent and Selective CCR4 Antagonist That Inhibits T<sub>reg</sub> Trafficking into the Tumor Microenvironment
Jeffrey J Jackson, John M Ketcham, Ashkaan Younai, et al.
Nature
|
February 25, 2026
Functional dissection of complex trait variants at single-nucleotide resolution
Layla Siraj, Rodrigo I Castro, Hannah B Dewey, et al.
Cell
|
November 26, 2013
Coexpression networks implicate human midfetal deep cortical projection neurons in the pathogenesis of autism
A Jeremy Willsey, Stephan J Sanders, Mingfeng Li, et al.
Nature Methods
|
March 20, 2024
Multicenter integrated analysis of noncoding CRISPRi screens
David Yao, Josh Tycko, Jin Woo Oh, et al.
Journal of Medicinal Chemistry
|
September 20, 2022
Potent GCN2 Inhibitor Capable of Reversing MDSC-Driven T Cell Suppression Demonstrates In Vivo Efficacy as a Single Agent and in Combination with Anti-Angiogenesis Therapy
Jeffrey J Jackson, Grant M Shibuya, Buvana Ravishankar, et al.
Science (New York, N.Y.)
|
April 27, 2023
Leveraging base-pair mammalian constraint to understand genetic variation and human disease
Patrick F Sullivan, Jennifer R S Meadows, Steven Gazal, et al.
Page
of 28